5. Public Reporting as a Quality Improvement Strategy

Author, Year
(QA)
Baker 2002 5
(Fair)
9. Context:
Decisionmaker
Characteristics
10. Context:
Type of
Patients or Payers Selection of
hospitals,
however
consequences
are not dire.
Decision/Choice 11. Results: KQ1: (Health Care Outcomes) 12. Results: KQ2 (Harms)
Unadjusted results:
RR for in hospital death:
Acute MI: -20.2% (95% CI, -31.1 to -8.0)
CHF: -4.7% (95% CI, -55.4 to -36.2)
COPD: -49.6% (95% CI, -65.4 to -26.8)
Pneumonia: -23.0% (95% CI, -32.1 to -12.1)
GI hemorrhage or Stroke: NS
RR for Early post discharge mortality rate:
Acute MI: 100.1% (95% CI, 43.2 to 178.9)
CHF: 57.4% (95% CI, 28.0 to 94.6)
GI hemorrhage: 101.0% (95% CI, 13.7 to
189.0)
Pneumonia: 85.8% (95% CI, 54.3 to 123.8)
Stroke: 121.4% (95% CI, 71.1 to 184.7)
COPD: NS
RR for 30-day mortality:
CHF: -12.4% (95% CI, -23.7 to 0.0)
Stroke: 25.3 (95% CI, 10.0 to 42.3)
Acute MI, GI hemorrhage, Pneumonia,
COPD: NS
Risk-adjusted mortality rates:
In hospital mortality:
Acute MI, GI hemorrhage, CHF, Pneumonia,
COPD had significant declines. Stroke was
NS.
Post discharge mortality rates:
Acute MI, GI hemorrhage, CHF, Pneumonia,
Stroke had significant increases. COPD was
NS.
30-day mortality rates:
H-30
PCI and/or CABG by NY versus non-
NY interaction: p=0.008
PCI and/or CABG: NY vs. Non-NY:
.73, .4-1.32
No PCI and/or CABG: NY vs. non-NY:
2.12**, 1.2-3.75
Propensity score: .89*, .81-.98
*** p